New Liposomal Therapy for Leishmaniasis
Author Information
Author(s): Roychoudhury Jayeeta, Sinha Roma, Ali Nahid
Primary Institution: Indian Institute of Chemical Biology, Jadavpur, Kolkata, India
Hypothesis
Can sodium stibogluconate in liposomes effectively treat SSG-resistant Leishmania donovani infections?
Conclusion
The study found that sodium stibogluconate in stearylamine-bearing liposomes effectively cured SSG-resistant Leishmania donovani infections in mice.
Supporting Evidence
- PC-SA-SSG suppressed liver parasitic load by 93% and 97% in two different strains of SSG-resistant L. donovani.
- PC-SA-SSG treatment resulted in a significant reduction of IL-10 and TGF-β levels.
- Treatment with PC-SA-SSG led to a strong Th1 immune response, indicated by increased IFN-γ production.
Takeaway
Researchers created a special medicine using liposomes to help treat a tough infection in mice, and it worked really well!
Methodology
The efficacy of sodium stibogluconate in different liposome formulations was tested in infected BALB/c mice, measuring parasite loads in various organs post-treatment.
Participant Demographics
BALB/c mice, 4-6 weeks old
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website